**Abstract**

***Background*:** Antipsychotic noncompliance commonly causes treatment failure in patients with schizophrenia. Although antipsychotics improve compliance by enhancing insight and social adaptive function, the polypharmacy regimen required to enhance efficacy may lead to noncompliance by elevating the risk of adverse reactions. Our study evaluated the effect of antipsychotic prescription patterns on compliance.

***Method*:** Data from the South Korean National Health Insurance Review and Assessment-National Population Sample-2011 was used for analysis. Among whole 1,375,842 people, 3236 subjects whose antipsychotic prescription pattern was well-maintained during observation period were included. Subjects whose antipsychotic prescription patterns were well maintained during the observation period were included. Demographic data, antipsychotic adherence, and antipsychotic monopharmacy/polypharmacy patterns were reviewed. Monopharmacy and polypharmacy regimens were classified into 6 groups: no antipsychotics, one first-generation antipsychotic, one second-generation antipsychotic, two or more first-generation antipsychotics, two or more second-generation antipsychotics, and a first-generation antipsychotic combined with a second-generation antipsychotic. The influence on antipsychotic adherence was investigated.

***Results*:** The good-adherence group contained a lower percentage of patients taking a single second-generation antipsychotic compared with that of patients taking two or more first-generation antipsychotics or those concurrently using a first and second-generation antipsychotic. Use of any antipsychotics was positively associated with adherence compared with no antipsychotics. However, no differences in adherence exist among the other five dosing patterns after adjustment for demographic and clinical data.

***Conclusions*:** It may not be necessary for clinicians to choose a monopharmacy regimen or to avoid first-generation antipsychotics for adherence in patients with schizophrenia. In addition, pharmacological therapy with high dose antipsychotics may be helpful in enhancing patient medication compliance.
